Process Research

Lupin's API Process Research program supports the Company's generics research program by developing new APIs that are either a first or by developing APIs that reduce costs dramatically. Our Process research efforts during FY 2012 were focussed on developing specialized and complex APIs like Prostaglandins, Hormones and a new class of ARVs meant for the US, EU, Japan and other advanced markets. In FY 2012, the Company filed 12 US DMFs taking the cumulative total to 123 DMF filings, 130 EDMFs/COSs and four JDMFs. Lupin ranked amongst the Top 10 globally in DMF filings for FY 2012.